The editors from The Journal of Clinical Endocrinology & Metabolism share their picks for the top breakthroughs in endocrine science from 2022. Editor-in-chief of JCEM, Paul M. Stewart, MD, FRCP, FMedSci, executive dean and professor at the University of Leeds School of Medicine in the United Kingdom says he “wanted something of an evidence to...
The editors from the Endocrine Society journal, Endocrinology, share their top picks for the outstanding endocrine discoveries of 2022. From the Editor-in-Chief of Endocrinology Editor-in-chief Carol A. Lange, PhD, professor of medicine (Division of Hematology, Oncology, and Transplantation) and pharmacology; Tickle Family Land Grant Endowed Chair of Breast Cancer Research; co-lead, Cellular Mechanisms of Cancer...
Endocrine News talks to editors from the Endocrine Society journal, Endocrine Reviews, to unearth the endocrine nuggets of 2022! This may go down as the “Gold Rush of ’22.” Maybe because researchers were more fully able to return to their labs this year after facing pandemic-related challenges for so long, or maybe just because it...
For the seventh year running, Endocrine News talks to editors from Endocrine Society publications to get the endocrine discoveries of 2021 worth their weight in gold. Research never stops. Despite facing challenges related to social distancing, supply chain disruptions, and other pandemic-related problems this past year, scientists dug deep in the mines of endocrinology and... Gender inequality persists in all sectors of society, including science and medicine disciplines. While female clinicians and researchers are increasing in number[1], they remain underrepresented in scholarly publications and academic positions[2]. Although nearly 50% of medical school graduates are women, they continue to hold fewer senior academic positions and tenured faculty posts than their male...
Real-World Study of More than 700,000 People with Type 2 Diabetes (T2D) Shows No Increased Risk of Below-Knee Lower Extremity Amputations with Canagliflozin Compared to Other Diabetes Medications A new real-world analysis of more than 700,000 U.S. T2D patients found no increased risk of below-knee lower extremity (BKLE) amputation with canagliflozin compared to other sodium glucose...
The following studies, among others, will be published in Endocrine Society journals. Before print, they are edited and posted online in each journal’s Early Release section. You can access the journals at www.endocrine.org. Subclinical Vascular Dysfunction Associated with Metabolic Syndrome in African Americans and Whites • Jia Shen, Joseph C. Poole, Matthew L. Topel, Aurelian...
Glucose Metabolism in High Risk Subjects for Type 2 Diabetes Carrying the rs7903146TCF7L2 Gene Variant • Giuseppe Daniele, Melania Gaggini, Mario Comassi, Cristina Bianchi, Giuseppina Basta, Angela Dardano, Roberto Miccoli, Andrea Mari, Amalia Gastaldelli, and Stefano Del Prato • In subjects at risk for T2DM, the TCF7L2 polymorphisms were associated with reduced Raex into systemic...
